Skip to main content

Chemotherapeutic Toxicity clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for
  • Serial PET MPI in Patients Undergoing Cancer Treatment

    Sorry, accepting new patients by invitation only

    This study aims to evaluate the effects of cardiotoxic cancer therapies on myocardial blood flow (MBF) and perfusion in a prospective sample of VA patients.

    Los Angeles, California

Our lead scientists for Chemotherapeutic Toxicity research studies include .

Last updated: